BBL
GILD icon

Beck Bode LLC’s Gilead Sciences GILD Stock Holding History

Beck Bode LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-398
Closed -$27K – 164
2021
Q2 		$27K Buy
+398
New +$26.6K 0.01% 174
2020
Q4 		– Sell
-98
Closed -$6K – 117
2020
Q3 		$6K Buy
+98
New +$6.8K ﹤0.01% 239

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Beck Bode LLC's GILD Position: Q3 2021 in Review

Beck Bode LLC sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 398 shares — an estimated $27K sold.

Beck Bode LLC first reported a position in GILD in Q3 2020 and held it in 2 quarters. The position peaked at $27K in Q2 2021. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Beck Bode LLC reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
  • Beck Bode LLC sold 398 Gilead Sciences shares in Q3 2021, an estimated $27K.
  • Beck Bode LLC first reported a position in Gilead Sciences in Q3 2020 and held it in 2 quarters.
  • Beck Bode LLC's Gilead Sciences position peaked at $27K in Q2 2021.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.